These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3203704)

  • 1. Cyclosporin: pharmacokinetics and detailed studies of plasma and erythrocyte binding during intravenous and oral administration.
    Legg B; Gupta SK; Rowland M; Johnson RW; Solomon LR
    Eur J Clin Pharmacol; 1988; 34(5):451-60. PubMed ID: 3203704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacokinetics of cyclosporin.
    Ptachcinski RJ; Venkataramanan R; Burckart GJ
    Clin Pharmacokinet; 1986; 11(2):107-32. PubMed ID: 3514043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiologic modeling of cyclosporin kinetics in rat and man.
    Bernareggi A; Rowland M
    J Pharmacokinet Biopharm; 1991 Feb; 19(1):21-50. PubMed ID: 2023108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Saturable binding of cyclosporin A to erythrocytes: estimation of binding parameters in renal transplant patients and implications for bioavailability assessment.
    Legg B; Rowland M
    Pharm Res; 1988 Feb; 5(2):80-5. PubMed ID: 3073383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of cyclosporin: influence of rate of constant intravenous infusion in renal transplant patients.
    Gupta SK; Legg B; Solomon LR; Johnson RW; Rowland M
    Br J Clin Pharmacol; 1987 Oct; 24(4):519-26. PubMed ID: 3318898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of cyclosporin: influence of rate-duration profile of an intravenous infusion in renal transplant patients.
    Gupta SK; Bakran A; Johnson RW; Rowland M
    Br J Clin Pharmacol; 1989 Mar; 27(3):353-7. PubMed ID: 2655684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of cyclosporine assay methodology in the immediate postoperative period of renal transplantation.
    Morse GD; Holdsworth MT; Walshe JJ
    Ther Drug Monit; 1989; 11(3):238-45. PubMed ID: 2658209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporin: erythrocyte binding and an examination of its use to estimate unbound concentration.
    Legg B; Rowland M
    Ther Drug Monit; 1988; 10(1):16-9. PubMed ID: 3376178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporin A blood levels during use of cyclosporin as oral solution or in capsules: comparison of pharmacokinetic parameters.
    Hilbrands LB; Hoitsma AJ; van den Berg JW; Koene RA
    Transpl Int; 1991 Jun; 4(2):125-7. PubMed ID: 1910430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vivo distribution and erythrocyte binding characteristics of cyclosporin in renal transplant patients.
    Kurokawa N; Kadobayashi M; Yamamoto K; Arakawa Y; Sawada M; Takahara S; Okuyama A; Yanaihara C
    J Pharm Pharmacol; 1996 Jun; 48(6):553-9. PubMed ID: 8832486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Area under the curve monitoring of cyclosporine therapy: the early posttransplant period.
    Grevel J; Kahan BD
    Ther Drug Monit; 1991 Mar; 13(2):89-95. PubMed ID: 2053129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of effect of spiramycin on cyclosporin pharmacokinetics.
    Vernillet L; Bertault-Peres P; Berland Y; Barradas J; Durand A; Olmer M
    Br J Clin Pharmacol; 1989 Jun; 27(6):789-94. PubMed ID: 2667601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporin-erythromycin interaction in renal transplant patients.
    Gupta SK; Bakran A; Johnson RW; Rowland M
    Br J Clin Pharmacol; 1989 Apr; 27(4):475-81. PubMed ID: 2655690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A model to account for the variation in cyclosporin binding to plasma lipids in transplant patients.
    Legg B; Gupta SK; Rowland M
    Ther Drug Monit; 1988; 10(1):20-7. PubMed ID: 3287705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nyctohemeral variations of cyclosporine administered orally in renal transplant patients].
    Ramon M; Morel D; Penouil F; Grellet J; Potaux L; Saux MC; Brachet-Liermain A
    Therapie; 1989; 44(5):371-4. PubMed ID: 2814916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporin A pharmacokinetics in liver transplant recipients in relation to biliary T-tube clamping and liver dysfunction.
    Naoumov NV; Tredger JM; Steward CM; O'Grady JG; Grevel J; Niven A; Whiting B; Williams R
    Gut; 1989 Mar; 30(3):391-6. PubMed ID: 2651227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of cyclosporine G in patients with renal failure.
    Wenk M; Bindschedler M; Costa E; Zuber M; Vozeh S; Thiel G; Abisch E; Keller HP; Beveridge T; Follath F
    Transplantation; 1988 Mar; 45(3):558-61. PubMed ID: 3347936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of food on the pharmacokinetics of cyclosporine in healthy subjects following oral and intravenous administration.
    Gupta SK; Manfro RC; Tomlanovich SJ; Gambertoglio JG; Garovoy MR; Benet LZ
    J Clin Pharmacol; 1990 Jul; 30(7):643-53. PubMed ID: 2391396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of cyclosporin in man following a single oral dose: relationship to body fat content.
    Waters MR; Albano JD; Sharman VL; Raman GV
    Nephrol Dial Transplant; 1989; 4(1):71-4. PubMed ID: 2494602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of cyclosporin G (NVa2 cyclosporin) in blood and plasma.
    Yatscoff RW; Honcharik N; Lukowski M; Thliveris J; Chackowsky P; Faraci C
    Clin Chem; 1993 Feb; 39(2):213-7. PubMed ID: 8432008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.